1998
DOI: 10.3109/10428199809057602
|View full text |Cite
|
Sign up to set email alerts
|

Primary Cutaneous T-Cell Lymphoma Involving the Cheek: An Infant Case with a Unique Clinicopathologic Feature

Abstract: We report a clinicopathologic feature of primary cutaneous T-cell lymphoma (CTCL) in a five-year-old boy with increasing swelling of his cheek since two years of age. Histologically, an infiltrate of atypical lymphoid cells with mature T-cell phenotype and clonality was prominent from the dermis to the subcutaneous tissue of the cheek. Although little effect was seen with aggressive multidrug-combined chemotherapy, therapy with interferon-alpha and steroids achieved a prolonged remission. This patient may prov… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
7
0

Year Published

2004
2004
2017
2017

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 12 publications
0
7
0
Order By: Relevance
“…This underscores the importance of continued follow-up of patients given the diagnosis of CHP and the need to perform repeated biopsies if warranted. 14 15/F CHOP, cyclosporine In remission at 9 mo 38 15 3/M Multidrug chemotherapy # Alive at 8 y 49 16 3/M Multidrug chemotherapy** Alive at 2 y 49 CHOP, Cyclophosphamide, doxorubicin, vincristine, and prednisolone; DIC, disseminated intravascular coagulation; F, female; HPS, hemophagocytic syndrome; M, male. *Cyclophosphamide, Adriamycin, vincristine, prednisolone, and etoposide (CHOP-E).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This underscores the importance of continued follow-up of patients given the diagnosis of CHP and the need to perform repeated biopsies if warranted. 14 15/F CHOP, cyclosporine In remission at 9 mo 38 15 3/M Multidrug chemotherapy # Alive at 8 y 49 16 3/M Multidrug chemotherapy** Alive at 2 y 49 CHOP, Cyclophosphamide, doxorubicin, vincristine, and prednisolone; DIC, disseminated intravascular coagulation; F, female; HPS, hemophagocytic syndrome; M, male. *Cyclophosphamide, Adriamycin, vincristine, prednisolone, and etoposide (CHOP-E).…”
Section: Discussionmentioning
confidence: 99%
“…It typically presents with subcutaneous nodules and plaques. 2,5,[12][13][14][15][16][17] Systemic symptoms are common, particularly fever and malaise. Patients may initially present with CHP, a form of panniculitis characterized histologically by lobular panniculitis with proliferation of benign-appearing cytophagic histiocytes.…”
Section: Discussionmentioning
confidence: 99%
“…In the immunohistochemistry, two subtypes are described: the alpha/beta with an indolent course and favorable prognosis and the gamma/delta, which has an aggressive course and a greater association with hematopagocytic syndrome. The estimated survival of the first is 80% and the second 10% to 5 years 21 . We reviewed 9 pediatric cases described in the literature [17][18][19][20][21][22][23] , and we found some similar features with the present clinical case, as the presence of erythematous-violaceous non-ulcerated few sensitive nodules in the anterior abdominal wall, dorsum and extremities, nodules of insidious installation and evolution in outbreaks.…”
Section: Discussionmentioning
confidence: 99%
“…The estimated survival of the first is 80% and the second 10% to 5 years 21 . We reviewed 9 pediatric cases described in the literature [17][18][19][20][21][22][23] , and we found some similar features with the present clinical case, as the presence of erythematous-violaceous non-ulcerated few sensitive nodules in the anterior abdominal wall, dorsum and extremities, nodules of insidious installation and evolution in outbreaks. In 6 of the 9 cases there was concomitance with PFS and 7 of them, kept their weight 17,18,22,23 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation